Free Case Evaluation
RISPERDAL® CONSTA® (risperidone) is approved for the treatment of schizophrenia and for the maintenance treatment of Bipolar I Disorder.
Risperdal is used to treat schizophrenia and symptoms of bipolar disorder (manic depression). Risperdal is also used in autistic children to treat symptoms of irritability.
Families are filing legal claims against Johnson & Johnson and its Janssen Group alleging that atypical antipsychotic drugs Risperdal and Invega cause male breast tissue enlargement. Known as gynecomastia, the emotionally damaging condition can lead to boys needing mastectomies (removal of the breasts).
Taking antipsychotic medication during the last 3 months of pregnancy may cause problems in the newborn, such as withdrawal symptoms, breathing problems, feeding problems, fussiness, tremors, and limp or stiff muscles. However, you may have withdrawal symptoms or other problems if you stop taking your medicine during pregnancy. If you become pregnant while taking this medicine, do not stop taking it without your doctor’s advice.
Risperidone can pass into breast milk and may harm a nursing baby. Do not breast-feed while taking this medicine and for at least 12 weeks after your treatment ends..
Do not give this medicine to a child without a doctor’s advice.
The U.S. Department of Justice said J&J illegally marketed Risperdal andInvega. According to a former Johnson & Johnson sales manager, the company didn’t wait to obtain FDA approval before promoting its use for children..